Palbociclib and endocrine therapy in fourth line and beyond for hormone receptor-positive HER2-negative advanced breast cancer: The UK compassionate access program experience

被引:0
|
作者
Battisti, N. M. L.
Kingston, B.
King, J.
Denton, A.
Waters, S.
Sita-Lumsden, A.
Rehman, F.
Stavraka, C.
Kristeleit, H.
Sawyer, E.
Houghton, D.
Davidson, N.
Howell, S.
Choy, J.
Harper, P.
Roylance, R.
Fharat, R.
Mohammed, K.
Ring, A.
Johnston, S.
机构
[1] Royal Marsden NHS Fdn Trust, London, England
[2] Royal Free London NHS Fdn Trust, London, England
[3] East & North Herts NHS Trust, Stevenage, Herts, England
[4] Velindre Canc Ctr, Cardiff, S Glam, Wales
[5] Imperial Coll Healthcare NHS Trust, London, England
[6] Guys & St Thomas NHS Fdn Trust, London, England
[7] Kings Coll London, Sch Canc & Pharmaceut Sci, London, England
[8] Ramsay Hlth Care UK Rivers Hosp, Sawbridgeworth, England
[9] Christie NHS Fdn Trust, Manchester, Lancs, England
[10] LOC Leaders Oncol Care, London, England
[11] Univ Coll London Hosp NHS Fdn Trust, London, England
关键词
D O I
10.1158/1538-7445.SABCS18-P6-18-23
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P6-18-23
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience
    Battisti, Nicolo Matteo Luca
    Kingston, Belinda
    King, Judy
    Denton, Arshi
    Waters, Simon
    Sita-Lumsden, Ailsa
    Rehman, Farah
    Stavraka, Chara
    Kristeleit, Hartmut
    Sawyer, Elinor
    Houghton, David
    Davidson, Neville
    Howell, Sacha
    Choy, Julia
    Harper, Peter
    Roylance, Rebecca
    Fharat, Raja
    Mohammed, Kabir
    Ring, Alistair
    Johnston, Stephen
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (03) : 731 - 740
  • [2] Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience
    Nicolò Matteo Luca Battisti
    Belinda Kingston
    Judy King
    Arshi Denton
    Simon Waters
    Ailsa Sita-Lumsden
    Farah Rehman
    Chara Stavraka
    Hartmut Kristeleit
    Elinor Sawyer
    David Houghton
    Neville Davidson
    Sacha Howell
    Julia Choy
    Peter Harper
    Rebecca Roylance
    Raja Fharat
    Kabir Mohammed
    Alistair Ring
    Stephen Johnston
    Breast Cancer Research and Treatment, 2019, 174 : 731 - 740
  • [3] Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer
    Maurer, Christian
    Ferreira, Arlindo R.
    Martel, Samuel
    Lambertini, Matteo
    Ponde, Noam
    Aftimos, Philippe
    de Azambuja, Evandro
    Piccart, Martine
    BREAST, 2018, 39 : 14 - 18
  • [4] Toxicity and efficacy of Palbociclib with endocrine therapy of physician's choice in fourth line and beyond for hormone receptor-positive HER2-negative advanced breast cancer: A single centre experience.
    Battisti, Nicolo Matteo Luca
    Kingston, Belinda
    Mohammed, Kabir
    Johnston, Stephen R. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Abemaciclib and endocrine therapy for hormone receptor-positive, HER2-negative advanced breast cancer: A real-world UK multicentre experience
    Battisti, Nicolo Matteo Luca
    Morrison, Laura
    Nash, Tamsin
    Senthivel, Nishanti
    Kestenbaum, Samantha
    Begum, Parvin
    Obeid, Mariam
    Hayhurst, William
    Yang, Dorothy
    Gafoor, Shafiah
    Brown, Caroline
    Rehman, Farah
    Kenny, Laura
    Hatcher, Olivia
    Susan, Susan
    Williams, Jennet
    Brown, Anna
    Rozati, Hamoun
    Alexandros, Alexandros
    Sawyer, Elinor
    Gousis, Charalampos
    Karapanagiotou, Eleni
    Rigg, Anna
    Rapti, Kleopatra
    Roylance, Rebecca
    Beresford, Mark
    Gee, Abigail L.
    Konstantis, Apostolos
    King, Judy
    Nathan, Mark
    Spurrell, Emma
    Pearce, Mark
    Bradwell, Dane
    Denton, Arshi
    Swain, Kate
    McGrath, Sophie
    Allen, Mark
    Ring, Alistair
    Johnston, Stephen
    Raja, Fharat
    CANCER RESEARCH, 2022, 82 (04)
  • [6] Efficacy of palbociclib after everolimus in hormone receptor-positive, HER2-negative advanced breast cancer.
    Kovac, Anja
    Kuhar, Cvetka Grasic
    Ovcaricek, Tanja
    Matos, Erika
    Mencinger, Marina
    Borstnar, Simona
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity
    Frassoldati, Antonio
    Biganzoli, Laura
    Bordonaro, Roberto
    Cinieri, Saverio
    Conte, Pierfranco
    De Laurentis, Michelino
    Del Mastro, Lucia
    Gori, Stefania
    Lauria, Rossella
    Marchetti, Paolo
    Michelotti, Andrea
    Montemurro, Filippo
    Naso, Giuseppe
    Pronzato, Paolo
    Puglisi, Fabio
    Tondini, Carlo Alberto
    FUTURE ONCOLOGY, 2020, 16 (05) : 129 - 145
  • [8] Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series
    Schettini, Francesco
    De Santo, Irene
    Rea, Carmen G.
    Viggiani, Martina
    Buono, Giuseppe
    De Angelis, Carmine
    Cardalesi, Cinzia
    Lauria, Rossella
    Giuliano, Mario
    Forestieri, Valeria
    Thomas, Guglielmo
    Maione, Pierfrancesco
    Limite, Gennaro
    Accurso, Antonello
    Malorni, Luca
    De Placido, Sabino
    Arpino, Grazia
    MOLECULAR AND CLINICAL ONCOLOGY, 2020, 12 (05) : 456 - 460
  • [9] Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer
    Cantini, Luca
    Trapani, Dario
    Guidi, Lorenzo
    Bielo, Luca Boscolo
    Scafetta, Roberta
    Koziej, Marcin
    Vidal, Laura
    Saini, Kamal S.
    Curigliano, Giuseppe
    CANCER TREATMENT REVIEWS, 2024, 123
  • [10] Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial
    Demir, Atakan
    Mandel, Nil Molinas
    Paydas, Semra
    Demir, Gokhan
    Er, Ozlem
    Turhal, Nazim Serdal
    Bavbek, Sevil
    Eralp, Yesim
    Saip, Pinar Mualla
    Guler, Emine Nilufer
    Aydiner, Adnan
    Uluc, Basak Oyan
    Kilickap, Sadettin
    Uskent, Necdet
    Karadurmus, Nuri
    Kaplan, Mehmet Ali
    Yanmaz, Mustafa Teoman
    Demir, Hacer
    Alan, Ozkan
    Korkmaz, Taner
    Olgun, Polat
    Uysal, Ozlem Sonmez
    Altundag, Kadri
    Gunduz, Seyda
    Gunaldi, Meral
    Sari, Murat
    Beypinar, Ismail
    Basaran, Gul
    BALKAN MEDICAL JOURNAL, 2020, 37 (02) : 104 - 107